Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study

Código QR

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study

Jing Liu,1– 3 Liying Guan,4 Meng Zhao,1,2,5 Qihang Li,2,3,5 An Song,6 Ling Gao,2,7,8 Haiyan Lin,4 Jiajun Zhao1,2,5,7 1Department of Endocrinology, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People’s Republic of China; 2...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu J, Guan L, Zhao M, Li Q, Song A, Gao L, Lin H, Zhao J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	triglyceride–glucose index nonalcoholic fatty liver disease outcomes Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/eb54624c2edb4bb3ba08c8d347a55bc7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
por: Valkov I., et al.
Publicado: (2017)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
por: Ekaterina E. Mishina, et al.
Publicado: (2017)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach
por: Yang T, et al.
Publicado: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Na Fei, et al.
Publicado: (2020)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice
por: Hui Chen, et al.
Publicado: (2021)

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
por: Shen HC, et al.
Publicado: (2014)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
por: A. V. Bogolyubova, et al.
Publicado: (2019)

The Triglyceride–Glucose Index is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Hospital-Based, Nested, Case–Control Study
por: Yao L, et al.
Publicado: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway
por: Yang P, et al.
Publicado: (2019)

Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
por: Gandha N, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks
por: Cheung A, et al.
Publicado: (2021)

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics
por: Emma J. Robinson, et al.
Publicado: (2021)

Association of insulin resistance and non-alcoholic fatty liver disease
por: Ekaterina E. Mishina, et al.
Publicado: (2021)

Potential relation between non-alcoholic fatty liver disease and glycemic and metabolic parameters in subjects without diabetes
por: H. Naguib, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Marat Fudim, et al.
Publicado: (2021)

Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
por: Ye Lu, et al.
Publicado: (2021)

The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan
por: Lee YS, et al.
Publicado: (2021)

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yoseph Asmelash Gebru, et al.
Publicado: (2021)

Higher Triglyceride–Glucose Index Is Associated With Increased Likelihood of Kidney Stones
por: Zheng Qin, et al.
Publicado: (2021)

Identification of Hepatic Steatosis in Premenopausal and Postmenopausal Women Based on Phenotypes Combining Triglyceride Levels and Anthropometric Indices: A Cross-Sectional Study
por: Liu PJ, et al.
Publicado: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar R, et al.
Publicado: (2018)

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
por: Szanto KB, et al.
Publicado: (2019)

The Predictive Ability of Two Triglyceride-Associated Indices for Gestational Diabetes Mellitus and Large for Gestational Age Infant Among Chinese Pregnancies: A Preliminary Cohort Study
por: Liu PJ, et al.
Publicado: (2020)

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
por: Irina A. Khripun, et al.
Publicado: (2019)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
por: Xiaojiaoyang Li, et al.
Publicado: (2021)

Screening for Metabolic Syndrome Using an Integrated Continuous Index Consisting of Waist Circumference and Triglyceride: A Preliminary Cross-sectional Study
por: Liu PJ, et al.
Publicado: (2020)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang J, et al.
Publicado: (2021)

Comparison of the Effects of Clozapine, Olanzapine and Risperidone with Haloperidol on Fasting Blood Level of Glucose, Cholesterol and Triglyceride in Patients with Psychotic Disorders
por: A Masoudzadeh, et al.
Publicado: (2009)

Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis
por: Yu-Chi Chen, et al.
Publicado: (2021)